# Artemisinin-Based Combination Therapy: Clinical Trials in Cameroon

> **NCT00297882** · PHASE3 · COMPLETED · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 816 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** 1. Artemether-Lumefantrine (AL)
- **DRUG:** 2. Amodiaquine-Artesunate (AQ-AS)

## Key facts

- **NCT ID:** NCT00297882
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2009-04
- **Final completion:** 2009-07
- **Target enrollment:** 816 (ACTUAL)
- **Last updated:** 2021-06-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00297882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00297882, "Artemisinin-Based Combination Therapy: Clinical Trials in Cameroon". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00297882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*